RCM
VXRT

Ratan Capital Management’s Vaxart VXRT Stock Holding History

Ratan Capital Management’s Portfolio VXRT Stock Details VXRT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-4,119
Closed -$189K – 28
2013
Q3 		$189K Hold
4,119
– – 0.06% 27
2013
Q2 		$156K Buy
+4,119
New +$171K 0.08% 24

Other funds holding VXRT

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
GCIA
Gabelli & Co Investment Advisers Rye, New York $674M AUM 64.52% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
TL
TowerView LLC New York $155M AUM 30.14% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
HVC
Healthcare Value Capital Woodcliff Lake, New Jersey $50.7M AUM 24.72% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Ratan Capital Management's VXRT Position: Q4 2013 in Review

Ratan Capital Management sold out of Vaxart (VXRT) in Q4 2013, closing a stake of 4,119 shares — an estimated $189K sold.

Ratan Capital Management first reported a position in VXRT in Q2 2013 and held it in 2 quarters. The position peaked at $189K in Q3 2013. 42 funds tracked by Wall St. Rank hold VXRT as of Q4 2013.

  • Ratan Capital Management reported no remaining Vaxart position as of Q4 2013 after selling out during the quarter.
  • Ratan Capital Management sold 4,119 Vaxart shares in Q4 2013, an estimated $189K.
  • Ratan Capital Management first reported a position in Vaxart in Q2 2013 and held it in 2 quarters.
  • Ratan Capital Management's Vaxart position peaked at $189K in Q3 2013.
  • 42 funds tracked by Wall St. Rank held Vaxart as of Q4 2013.

Based on Ratan Capital Management's 13F filing for Q4 2013, filed 14 Feb 2014.